Clinical Trial Update: Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating pharmacokinetics, efficacy, and safety of human plasma-derived fibrinogen (FIB Grifols) in adults with congenital afibrinoge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Afibrinogenemia

Drugs mentioned

• FIB Grifols (fibrinogen (human plasma-derived))

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Congenital Afibrinogenemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-29